Upgrade to SI Premium - Free Trial

Travere Therapeutics (TVTX) PT Raised to $54 at Guggenheim

April 14, 2026 7:04 AM
(Updated - April 14, 2026 7:08 AM EDT)

Guggenheim analyst Vamil Divan raised the price target on Travere Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change